USFDA inspection: Zydus Lifesciences and Gland Pharma
Drug Approval

USFDA inspection: Zydus Lifesciences and Gland Pharma

The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam

  • By IPP Bureau | January 28, 2023

Zydus Lifesciences facility at Moraiya

Zydus Lifesciences Limited has informed that the USFDA conducted an inspection at the manufacturing facility at Moraiya, Ahmedabad from 23rd to 27th January, 2023. The inspection was a Pre-Approval Inspection (PAI) for Transdermal Patch products. The inspection concluded with nil observations.

Gland Pharma's Visakhapatnam facility 

The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam from 23rd January, 2023 to 27th January, 2023 and has been completed with Zero observations.

Upcoming E-conference

Other Related stories

Startup

Digitization